The Q2 beat and guidance raise—especially the first organic revenue growth since 2023 and the highest DSA book-to-bill in nearly four years—suggest a cyclical recovery in drug development outsourcing. The company's Investor Day on September 24, 2026 will provide further strategic detail. Traders should watch for continued order momentum and margin expansion as the divested businesses are behind the company.
Price Chart
Executive Summary
Charles River Laboratories reported Q2 2026 revenue of $1.00B (down 2.7% reported / +0.1% organic YoY) and non-GAAP EPS of $3.02, beating consensus estimates of $2.73 by 10.6%. The company raised its full-year organic revenue guidance to 0.0%-1.0% (from -1.5% to -0.5%) and its non-GAAP EPS guidance to $11.15-$11.45, driven by improving demand in DSA and better-than-expected Manufacturing performance. This marks the first quarter of organic revenue growth since Q3 2023 and signals a potential inflection in underlying demand trends.
Key Financial Metrics
Key Facts
- Q2 2026 total revenue $1.00B vs consensus $977.2M; organic revenue grew 0.1% YoY (first positive since Q3 2023)
- Non-GAAP EPS $3.02 beats consensus of $2.73 by 10.6% (down 3.2% from $3.12 a year ago)
- Raised 2026 organic revenue guidance to 0.0%-1.0% from (1.5%)-(0.5%) and non-GAAP EPS to $11.15-$11.45 from $10.80-$11.30
- GAAP net loss of $(0.03)/share driven by $63.7M loss on CDMO & Cell Solutions divestiture completed in May 2026
- Non-GAAP operating margin 20.5% improved 420 bps sequentially from Q1 2026 (16.3%) but down 160 bps YoY
- Repurchased $100M of common stock in Q2 at avg price $174; $700M remaining under $1.0B authorization
- DSA segment achieved highest net book-to-bill in nearly four years, indicating strengthening demand
- Completed divestitures of CDMO, Cell Solutions, and certain European Discovery Services sites in May 2026
Financial Impact
Non-GAAP EPS beat of $0.29 vs consensus ($3.02 vs $2.73) and full-year guidance raised by $0.25 at midpoint; revenue beat of $27M vs consensus
Risk Factors
- RMS organic revenue declined 1.4% YoY, and non-GAAP operating margin contracted in all three segments
- Non-GAAP EPS guidance increase partly offset by higher tax rate and deferred comp investment gains that may not recur
- Guidance assumes successful execution of restructuring and efficiency initiatives; any delays could pressure margins
- GAAP earnings remain deeply negative due to divestiture-related charges; underlying cash flow metrics warrant monitoring
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001100682-26-000115 |
| Document: crl-20260805.htm | 0001100682-26-000115 |
| Document: 0001100682-26-000115-index-headers.html | 0001100682-26-000115 |
| Document: 0001100682-26-000115-index.html | 0001100682-26-000115 |
| Document: 0001100682-26-000115.txt | 0001100682-26-000115 |
| 8-K Data (Synthetic) | 0001100682-26-000115 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Insider Cluster | $296.41 $294.44 | ▼ −0.66% | ▼ −0.16% | $290.19 (−2.10%) |
Aug 20, 2026 6w ago | Insider Cluster | $291.45 $278.06 | ▼ −4.59% | ▼ −4.59% | $290.19 (−0.43%) |
Aug 13, 2026 7w ago | Insider Cluster | $281.27 $278.26 | ▼ −1.07% | ▲ +0.68% | $290.19 (+3.17%) |
Aug 11, 2026 7w ago | Insider Cluster | $282.00 $278.35 | ▼ −1.29% | ▼ −0.24% | $290.19 (+2.90%) |
Aug 10, 2026 7w ago | Insider Cluster | $282.00 $278.35 | ▼ −1.29% | ▼ −0.24% | $290.19 (+2.90%) |
Aug 5, 2026 8w ago | 8-K | $260.72 $291.76 | ▲ +11.91% | ▲ +12.51% | $290.19 (+11.30%) |
May 7, 2026 21w ago | 8-K | $180.78 $179.87 | ▲ +0.51% | ▲ +3.64% | $290.19 (−60.52%) |
Feb 25, 2026 31w ago | 8-K | $167.50 $164.89 | ▼ −1.56% | ▲ +3.68% | $290.19 (+73.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access